Replacement of Major Antibody Raw Materials with Silkworm-Derived Materials
First written in FY2016. 3 of 5 entries say "Restated". Latest entry: FY2020.
No other company in this theme has enough history to compare yet.
- FY2020RestatedAnnual report
「Using this technology, we switched the antibody used in our amyloid-β measurement kit to an antibody produced by genetically modified silkworms, and also supply antibodies to a major in vitro diagnostic products manufacturer.」
The company continues to use silkworm-produced antibodies in its measurement kits and supply them to a major in vitro diagnostic products manufacturer. - FY2019RestatedAnnual report
「In addition, using this technology, we switched the antibody used in our amyloid-β measurement kit to an antibody produced by genetically modified silkworms and also supply antibodies to a major in vitro diagnostic products manufacturer.」
The company continues to use silkworm-produced antibodies in its amyloid-β measurement kit and supply them to a major in vitro diagnostic products manufacturer. - FY2018-Q1RestatedAnnual report
「Using this technology, we switched the antibody used in our amyloid-β measurement kit to an antibody produced by genetically modified silkworms, and also supply antibodies to a major in vitro diagnostic products manufacturer.」
The company switched the antibody raw material in its amyloid-β measurement kit to silkworm-produced antibodies and continues to supply them to a major external in vitro diagnostic products manufacturer. - FY2017AdvancedAnnual report
「Using this technology, we switched the antibody used in our amyloid-β measurement kit to an antibody produced by genetically modified silkworms, and also supply antibodies to a major in vitro diagnostic products manufacturer.」
The company switched the antibody raw material in its amyloid-β measurement kit to silkworm-produced antibodies and also supplies them to a major external in vitro diagnostic products manufacturer. - FY2016First statedAnnual report
「We have successfully produced the key monoclonal antibodies currently used in our group products in genetically modified silkworm cocoons and have begun manufacturing products using silkworm-derived raw materials in place of the antibody raw materials currently used.」
The company stated that it had begun manufacturing products using silkworm-derived raw materials in place of the key monoclonal antibody raw materials.